Prevalence of Hypertension in Sudanese Patients With Gouty Arthritis
- PMID: 35602803
- PMCID: PMC9116687
- DOI: 10.7759/cureus.24248
Prevalence of Hypertension in Sudanese Patients With Gouty Arthritis
Abstract
Background In this study, we aimed to study the frequency of hypertension in Sudanese patients with gouty arthritis attending the largest three tertiary hospitals in Khartoum and correlate it with serum uric acid levels. Methodology An observational, descriptive, cross-sectional, hospital-based study was conducted in rheumatology clinics in Khartoum state, Sudan, from August 2020 to January 2021 involving 100 participants. Data were collected, prepared, and analyzed using SPSS version 25.0 (IBM Corp., Armonk, NY, USA). Results In this study, 100 participants were enrolled. The majority were males (79%), with 45% of the participants in the age group of 61-75 years. Overall, 89% of participants had symptoms of gouty arthritis, with the knee being the most common joint affected in 27% of participants. Most participants had a uric acid level above the target (6 mg/dL). The most frequently used uric acid lowering agent was found to be allopurinol in 85% of the patients. Furthermore, among those with gouty arthritis, 51% had hypertension with nearly half being insufficiently controlled. The frequency of undiagnosed hypertension among the participants was found to be 19%, which was statistically significant among gouty arthritis patients (p-value < 0.0001). Upon further analysis of our hypertensive participants, 79.5% of males (n = 35) had high blood pressure levels, which was statistically significant as well (p-value = 0.005), with the highest prevalence being among the age group of 61-75 years. Of those who were hypertensive, 51% had a history of concomitant comorbidity. Overall, 90% of the hypertensive participants (n = 40) had joint symptoms. Moreover, serum uric acid level was above the target in 93% of the participants. Conclusions Hypertension was found to be the most frequently recognized comorbidity in gouty arthritic patients, with more than a third remaining undiagnosed. Moreover, the male gender was a significant risk factor for hypertension among the gouty arthritis participants. Nevertheless, most patients with high blood pressure levels had concurrent elevated uric acid levels.
Keywords: allopurinol; arthralgia; gouty arthritis; hypertension; uric acid.
Copyright © 2022, Khaild et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Outcome of Treatment in Gouty Arthritis Patients: A Retrospective Study.J Med Assoc Thai. 2015 Apr;98 Suppl 3:S46-50. J Med Assoc Thai. 2015. PMID: 26387388
-
Prevalence of gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database.BMC Pediatr. 2020 Oct 15;20(1):481. doi: 10.1186/s12887-020-02379-0. BMC Pediatr. 2020. PMID: 33059648 Free PMC article.
-
Therapeutic Efficacy of Urinile Against Gouty Arthritis.Dose Response. 2020 Oct 4;18(4):1559325820946934. doi: 10.1177/1559325820946934. eCollection 2020 Oct-Dec. Dose Response. 2020. PMID: 33088246 Free PMC article.
-
Effect of nanoparticles on gouty arthritis: a systematic review and meta-analysis.BMC Musculoskelet Disord. 2023 Feb 14;24(1):124. doi: 10.1186/s12891-023-06186-3. BMC Musculoskelet Disord. 2023. PMID: 36788552 Free PMC article.
-
Comorbidities in gouty arthritis.J Investig Med. 2011 Dec;59(8):1211-20. doi: 10.2130/JIM.0b013e318239f660. J Investig Med. 2011. PMID: 22064605 Review.
Cited by
-
Gouty arthritis patients' diagnostic, biochemical, and hematological characteristics study: a single-center retrospective study.BMC Musculoskelet Disord. 2024 Dec 20;25(1):1054. doi: 10.1186/s12891-024-08151-0. BMC Musculoskelet Disord. 2024. PMID: 39707267 Free PMC article.
References
-
- Comorbidities in gout and hyperuricemia: causality or epiphenomena? Sumpter NA, Saag KG, Reynolds RJ, Merriman TR. Curr Opin Rheumatol. 2020;32:126–133. - PubMed
-
- Gaffo AL. UpToDate. Philadelphia, PA: Wolters Kluwer; 2022. Clinical manifestations and diagnosis of gout.
-
- Longitudinal transition trajectory of gouty arthritis and its comorbidities: a population-based study. Huang CF, Liu JC, Huang HC, Chuang SY, Chen CI, Lin KC. Rheumatol Int. 2017;37:313–322. - PubMed
-
- Prevalence of comorbidities and management of gout in a tropical city in Australia. Jeyaruban A, Soden M, Larkins S. Rheumatol Int. 2016;36:1753–1758. - PubMed
LinkOut - more resources
Full Text Sources